Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? - Boglione, L; Meli, G; Poletti, F; Rostagno, R; Moglia, R; Cantone, M; Esposito, M; Scianguetta, C; Domenicale, B; Di Pasquale, F; Borrè, S (QJM : An International Journal of Medicine, 2022)
Keywords: Adenosine Monophosphate - analogs & derivatives; Adenosine Monophosphate - therapeutic use; Alanine - analogs & derivatives; Alanine - therapeutic use; COVID-19 - complications; COVID-19 - drug therapy; Hospitalization; Humans; Incidence; Intensive Care Units; Original Paper; Prospective Studies; Risk Factors; SARS-CoV-2